Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 99 entries
Sorted by: Best Match Show Resources per page
Expanding The Capacity Of Nursing Education: Until the pipeline for advanced education in nursing is flowing freely, the nation's nurse workforce will have difficulty …

pipeline programs

McBride AB.
GSID: p4aFu_ECzGAJ
BL Cleary, AB McBride, ML McClure, SC Reinhard - Health Affairs, 2009 - healthaffairs.org

… graduates from primarily associate degree programs and, to a declining extent, hospital-based diploma programs. Educational pipeline. … The result is a lack of an adequate “pipeline” of candidates for graduate education. In other words, the nation has a...

Cite
Cleary, B. L., McBride, A. B., McClure, M. L., & Reinhard, S. C. (2009). Expanding The Capacity Of Nursing Education: Until the pipeline for advanced education in nursing is flowing freely, the nation's nurse workforce will have difficulty achieving its potential. Health Affairs, 28(Suppl3), w634-w645.‏
Cleary, Brenda L., et al. "Expanding The Capacity Of Nursing Education: Until the pipeline for advanced education in nursing is flowing freely, the nation's nurse workforce will have difficulty achieving its potential." Health Affairs 28.Suppl3 (2009): w634-w645.‏
Copy Download .nbib Format: MLA
Plerixafor as a salvage mobilization strategy for haploidentical peripheral blood allogeneic stem cell transplantation.

Clinical case reports

Nadeau M, George L, Yeager AM, Anwer F, McBride A.
PMID: 26401275
Clin Case Rep. 2015 Sep;3(9):728-30. doi: 10.1002/ccr3.327. Epub 2015 Jul 15.

In allogeneic stem cell mobilization, peripheral blood stem cell mobilization with filgrastim can be considered standard of care. Poor mobilizers may be at risk for inadequate stem cell collection during apheresis. He we present a successful case of salvage...

Cite
Nadeau M, George L, Yeager AM, et al. Plerixafor as a salvage mobilization strategy for haploidentical peripheral blood allogeneic stem cell transplantation. Clin Case Rep. 2015;3(9):728-30doi: 10.1002/ccr3.327.
Nadeau, M., George, L., Yeager, A. M., Anwer, F., & McBride, A. (2015). Plerixafor as a salvage mobilization strategy for haploidentical peripheral blood allogeneic stem cell transplantation. Clinical case reports, 3(9), 728-30. https://doi.org/10.1002/ccr3.327
Nadeau, Michelle, et al. "Plerixafor as a salvage mobilization strategy for haploidentical peripheral blood allogeneic stem cell transplantation." Clinical case reports vol. 3,9 (2015): 728-30. doi: https://doi.org/10.1002/ccr3.327
Nadeau M, George L, Yeager AM, Anwer F, McBride A. Plerixafor as a salvage mobilization strategy for haploidentical peripheral blood allogeneic stem cell transplantation. Clin Case Rep. 2015 Sep;3(9):728-30. doi: 10.1002/ccr3.327. Epub 2015 Jul 15. PMID: 26401275; PMCID: PMC4574786.
Copy Download .nbib Format: NLM
A Universal Vaccine against Leptospirosis: Are We Going in the Right Direction?.

Frontiers in immunology

Grassmann AA, Souza JD, McBride AJ.
PMID: 28337203
Front Immunol. 2017 Mar 09;8:256. doi: 10.3389/fimmu.2017.00256. eCollection 2017.

Leptospirosis is the most widespread zoonosis in the world and a neglected tropical disease estimated to cause severe infection in more than one million people worldwide every year that can be combated by effective immunization. However, no significant progress...

Cite
Grassmann AA, Souza JD, McBride AJ. A Universal Vaccine against Leptospirosis: Are We Going in the Right Direction?. Front Immunol. 2017;8:256doi: 10.3389/fimmu.2017.00256.
Grassmann, A. A., Souza, J. D., & McBride, A. J. (2017). A Universal Vaccine against Leptospirosis: Are We Going in the Right Direction?. Frontiers in immunology, 8256. https://doi.org/10.3389/fimmu.2017.00256
Grassmann, André Alex, et al. "A Universal Vaccine against Leptospirosis: Are We Going in the Right Direction?." Frontiers in immunology vol. 8 (2017): 256. doi: https://doi.org/10.3389/fimmu.2017.00256
Grassmann AA, Souza JD, McBride AJ. A Universal Vaccine against Leptospirosis: Are We Going in the Right Direction?. Front Immunol. 2017 Mar 09;8:256. doi: 10.3389/fimmu.2017.00256. eCollection 2017. PMID: 28337203; PMCID: PMC5343615.
Copy Download .nbib Format: NLM
Enterovirus D68 in Viet Nam (2009-2015).

Wellcome open research

Ny NTH, Anh NT, Hang VTT, Nguyet LA, Thanh TT, Ha DQ, Minh NNQ, Ha DLA, McBride A, Tuan HM, Baker S, Tam PTT, Phuc TM, Huong DT, Loi TQ, Vu NTA, Hung NV, Minh TTT, Xang NV, Dong N, Nghia HDT, Chau NVV, Thwaites G, van Doorn HR, Anscombe C, Le Van T.
PMID: 28852711
Wellcome Open Res. 2017 Jun 15;2:41. doi: 10.12688/wellcomeopenres.11558.2. eCollection 2017.

BACKGROUND: Since 1962, enterovirus D68 (EV-D68) has been implicated in multiple outbreaks and sporadic cases of respiratory infection worldwide, but especially in the USA and Europe with an increasing frequency between 2010 and 2014. We describe the detection, associated...

Cite
Ny NTH, Anh NT, Hang VTT, et al. Enterovirus D68 in Viet Nam (2009-2015). Wellcome Open Res. 2017;2:41doi: 10.12688/wellcomeopenres.11558.2.
Ny, N. T. H., Anh, N. T., Hang, V. T. T., Nguyet, L. A., Thanh, T. T., Ha, D. Q., Minh, N. N. Q., Ha, D. L. A., McBride, A., Tuan, H. M., Baker, S., Tam, P. T. T., Phuc, T. M., Huong, D. T., Loi, T. Q., Vu, N. T. A., Hung, N. V., Minh, T. T. T., Xang, N. V., Dong, N., Nghia, H. D. T., Chau, N. V. V., Thwaites, G., van Doorn, H. R., Anscombe, C., Le Van, T. (2017). Enterovirus D68 in Viet Nam (2009-2015). Wellcome open research, 241. https://doi.org/10.12688/wellcomeopenres.11558.2
Ny, Nguyen Thi Han, et al. "Enterovirus D68 in Viet Nam (2009-2015)." Wellcome open research vol. 2 (2017): 41. doi: https://doi.org/10.12688/wellcomeopenres.11558.2
Ny NTH, Anh NT, Hang VTT, Nguyet LA, Thanh TT, Ha DQ, Minh NNQ, Ha DLA, McBride A, Tuan HM, Baker S, Tam PTT, Phuc TM, Huong DT, Loi TQ, Vu NTA, Hung NV, Minh TTT, Xang NV, Dong N, Nghia HDT, Chau NVV, Thwaites G, van Doorn HR, Anscombe C, Le Van T. Enterovirus D68 in Viet Nam (2009-2015). Wellcome Open Res. 2017 Jun 15;2:41. doi: 10.12688/wellcomeopenres.11558.2. eCollection 2017. PMID: 28852711; PMCID: PMC5553084.
Copy Download .nbib Format: NLM
Regional variation in practitioner employment in general practices in England: a comparative analysis.

The British journal of general practice : the journal of the Royal College of General Practitioners

Spooner S, Gibson J, Checkland K, McBride A, Hodgson DE, Hann M, McDermott I, Sutton M.
PMID: 32041770
Br J Gen Pract. 2020 Feb 27;70(692):e164-e171. doi: 10.3399/bjgp20X708185. Print 2020 Mar.

BACKGROUND: In recent years, UK health policy makers have responded to a GP shortage by introducing measures to support increased healthcare delivery by practitioners from a wider range of backgrounds.AIM: To ascertain the composition of the primary care workforce...

Cite
Spooner S, Gibson J, Checkland K, et al. Regional variation in practitioner employment in general practices in England: a comparative analysis. Br J Gen Pract. 2020;70(692):e164-e171doi: 10.3399/bjgp20X708185.
Spooner, S., Gibson, J., Checkland, K., McBride, A., Hodgson, D. E., Hann, M., McDermott, I., & Sutton, M. (2020). Regional variation in practitioner employment in general practices in England: a comparative analysis. The British journal of general practice : the journal of the Royal College of General Practitioners, 70(692), e164-e171. https://doi.org/10.3399/bjgp20X708185
Spooner, Sharon, et al. "Regional variation in practitioner employment in general practices in England: a comparative analysis." The British journal of general practice : the journal of the Royal College of General Practitioners vol. 70,692 (2020): e164-e171. doi: https://doi.org/10.3399/bjgp20X708185
Spooner S, Gibson J, Checkland K, McBride A, Hodgson DE, Hann M, McDermott I, Sutton M. Regional variation in practitioner employment in general practices in England: a comparative analysis. Br J Gen Pract. 2020 Feb 27;70(692):e164-e171. doi: 10.3399/bjgp20X708185. Print 2020 Mar. PMID: 32041770; PMCID: PMC7015160.
Copy Download .nbib Format: NLM
Multiple Roles of Brd4 in the Infectious Cycle of Human Papillomaviruses.

Frontiers in molecular biosciences

McBride AA, Warburton A, Khurana S.
PMID: 34386523
Front Mol Biosci. 2021 Jul 27;8:725794. doi: 10.3389/fmolb.2021.725794. eCollection 2021.

Human Papillomaviruses (HPV) reproduce in stratified epithelia by establishing a reservoir of low- level infection in the dividing basal cells and restricting the production of viral particles to terminally differentiated cells. These small DNA viruses hijack pivotal cellular processes...

Cite
McBride AA, Warburton A, Khurana S. Multiple Roles of Brd4 in the Infectious Cycle of Human Papillomaviruses. Front Mol Biosci. 2021;8:725794doi: 10.3389/fmolb.2021.725794.
McBride, A. A., Warburton, A., & Khurana, S. (2021). Multiple Roles of Brd4 in the Infectious Cycle of Human Papillomaviruses. Frontiers in molecular biosciences, 8725794. https://doi.org/10.3389/fmolb.2021.725794
McBride, Alison A, et al. "Multiple Roles of Brd4 in the Infectious Cycle of Human Papillomaviruses." Frontiers in molecular biosciences vol. 8 (2021): 725794. doi: https://doi.org/10.3389/fmolb.2021.725794
McBride AA, Warburton A, Khurana S. Multiple Roles of Brd4 in the Infectious Cycle of Human Papillomaviruses. Front Mol Biosci. 2021 Jul 27;8:725794. doi: 10.3389/fmolb.2021.725794. eCollection 2021. PMID: 34386523; PMCID: PMC8353396.
Copy Download .nbib Format: NLM
Spatial and Functional Organization of Human Papillomavirus Replication Foci in the Productive Stage of Infection.

mBio

Khurana S, Markowitz TE, Kabat J, McBride AA.
PMID: 34749533
mBio. 2021 Nov 09;e0268421. doi: 10.1128/mBio.02684-21. Epub 2021 Nov 09.

The life cycle of human papillomavirus (HPV) depends on keratinocyte differentiation as the virus modulates and takes advantage of cellular pathways to replicate its genome and assemble viral particles in differentiated cells. Viral genomes are amplified in nuclear replication...

Cite
Khurana S, Markowitz TE, Kabat J, et al. Spatial and Functional Organization of Human Papillomavirus Replication Foci in the Productive Stage of Infection. mBio. 2021;e0268421doi: 10.1128/mBio.02684-21.
Khurana, S., Markowitz, T. E., Kabat, J., & McBride, A. A. (2021). Spatial and Functional Organization of Human Papillomavirus Replication Foci in the Productive Stage of Infection. mBio, e0268421. https://doi.org/10.1128/mBio.02684-21
Khurana, Simran, et al. "Spatial and Functional Organization of Human Papillomavirus Replication Foci in the Productive Stage of Infection." mBio vol. (2021): e0268421. doi: https://doi.org/10.1128/mBio.02684-21
Khurana S, Markowitz TE, Kabat J, McBride AA. Spatial and Functional Organization of Human Papillomavirus Replication Foci in the Productive Stage of Infection. mBio. 2021 Nov 09;e0268421. doi: 10.1128/mBio.02684-21. Epub 2021 Nov 09. PMID: 34749533; PMCID: PMC8576538.
Copy Download .nbib Format: NLM
Environmental indicators of biofuel sustainability: what about context?.

Environmental management

Efroymson RA, Dale VH, Kline KL, McBride AC, Bielicki JM, Smith RL, Parish ES, Schweizer PE, Shaw DM.
PMID: 22824960
Environ Manage. 2013 Feb;51(2):291-306. doi: 10.1007/s00267-012-9907-5. Epub 2012 Jul 24.

Indicators of the environmental sustainability of biofuel production, distribution, and use should be selected, measured, and interpreted with respect to the context in which they are used. The context of a sustainability assessment includes the purpose, the particular biofuel...

Cite
Efroymson RA, Dale VH, Kline KL, et al. Environmental indicators of biofuel sustainability: what about context?. Environ Manage. 2012;51(2):291-306doi: 10.1007/s00267-012-9907-5.
Efroymson, R. A., Dale, V. H., Kline, K. L., McBride, A. C., Bielicki, J. M., Smith, R. L., Parish, E. S., Schweizer, P. E., & Shaw, D. M. (2013). Environmental indicators of biofuel sustainability: what about context?. Environmental management, 51(2), 291-306. https://doi.org/10.1007/s00267-012-9907-5
Efroymson, Rebecca A, et al. "Environmental indicators of biofuel sustainability: what about context?." Environmental management vol. 51,2 (2013): 291-306. doi: https://doi.org/10.1007/s00267-012-9907-5
Efroymson RA, Dale VH, Kline KL, McBride AC, Bielicki JM, Smith RL, Parish ES, Schweizer PE, Shaw DM. Environmental indicators of biofuel sustainability: what about context?. Environ Manage. 2013 Feb;51(2):291-306. doi: 10.1007/s00267-012-9907-5. Epub 2012 Jul 24. PMID: 22824960.
Copy Download .nbib Format: NLM
A Smartphone-Based Self-management Intervention for Bipolar Disorder (LiveWell): User-Centered Development Approach.

JMIR mental health

Jonathan GK, Dopke CA, Michaels T, Bank A, Martin CR, Adhikari K, Krakauer RL, Ryan C, McBride A, Babington P, Frauenhofer E, Silver J, Capra C, Simon M, Begale M, Mohr DC, Goulding EH.
PMID: 33843607
JMIR Ment Health. 2021 Apr 12;8(4):e20424. doi: 10.2196/20424.

BACKGROUND: Bipolar disorder is a serious mental illness that results in significant morbidity and mortality. Pharmacotherapy is the primary treatment for bipolar disorder; however, adjunctive psychotherapy can help individuals use self-management strategies to improve outcomes. Yet access to this...

Cite
Jonathan GK, Dopke CA, Michaels T, et al. A Smartphone-Based Self-management Intervention for Bipolar Disorder (LiveWell): User-Centered Development Approach. JMIR Ment Health. 2021;8(4):e20424doi: 10.2196/20424.
Jonathan, G. K., Dopke, C. A., Michaels, T., Bank, A., Martin, C. R., Adhikari, K., Krakauer, R. L., Ryan, C., McBride, A., Babington, P., Frauenhofer, E., Silver, J., Capra, C., Simon, M., Begale, M., Mohr, D. C., & Goulding, E. H. (2021). A Smartphone-Based Self-management Intervention for Bipolar Disorder (LiveWell): User-Centered Development Approach. JMIR mental health, 8(4), e20424. https://doi.org/10.2196/20424
Jonathan, Geneva K, et al. "A Smartphone-Based Self-management Intervention for Bipolar Disorder (LiveWell): User-Centered Development Approach." JMIR mental health vol. 8,4 (2021): e20424. doi: https://doi.org/10.2196/20424
Jonathan GK, Dopke CA, Michaels T, Bank A, Martin CR, Adhikari K, Krakauer RL, Ryan C, McBride A, Babington P, Frauenhofer E, Silver J, Capra C, Simon M, Begale M, Mohr DC, Goulding EH. A Smartphone-Based Self-management Intervention for Bipolar Disorder (LiveWell): User-Centered Development Approach. JMIR Ment Health. 2021 Apr 12;8(4):e20424. doi: 10.2196/20424. PMID: 33843607; PMCID: PMC8076988.
Copy Download .nbib Format: NLM
Eutectic Mixture of Lidocaine and Prilocaine Decreases Movement and Propofol Requirements for Pediatric Lumbar Puncture During Deep Sedation: A Randomized, Placebo-Controlled, Double Blind Trial.

Journal of pediatric hematology/oncology

Hammon DE, Pearsall K, Smith NM, McBride AS, Bass AL, Tooze JA, McLean TW.
PMID: 33885035
J Pediatr Hematol Oncol. 2022 Jan 01;44(1):e213-e216. doi: 10.1097/MPH.0000000000002169.

Deep sedation/general anesthesia is commonly used in pediatric oncology patients undergoing lumbar puncture (LP). Propofol is often used for sedation, with or without a narcotic. We hypothesized that eutectic mixture of lidocaine and prilocaine (EMLA) would allow for lower...

Cite
Hammon DE, Pearsall K, Smith NM, et al. Eutectic Mixture of Lidocaine and Prilocaine Decreases Movement and Propofol Requirements for Pediatric Lumbar Puncture During Deep Sedation: A Randomized, Placebo-Controlled, Double Blind Trial. J Pediatr Hematol Oncol. 2022;44(1):e213-e216doi: 10.1097/MPH.0000000000002169.
Hammon, D. E., Pearsall, K., Smith, N. M., McBride, A. S., Bass, A. L., Tooze, J. A., & McLean, T. W. (2022). Eutectic Mixture of Lidocaine and Prilocaine Decreases Movement and Propofol Requirements for Pediatric Lumbar Puncture During Deep Sedation: A Randomized, Placebo-Controlled, Double Blind Trial. Journal of pediatric hematology/oncology, 44(1), e213-e216. https://doi.org/10.1097/MPH.0000000000002169
Hammon, Dudley E, et al. "Eutectic Mixture of Lidocaine and Prilocaine Decreases Movement and Propofol Requirements for Pediatric Lumbar Puncture During Deep Sedation: A Randomized, Placebo-Controlled, Double Blind Trial." Journal of pediatric hematology/oncology vol. 44,1 (2022): e213-e216. doi: https://doi.org/10.1097/MPH.0000000000002169
Hammon DE, Pearsall K, Smith NM, McBride AS, Bass AL, Tooze JA, McLean TW. Eutectic Mixture of Lidocaine and Prilocaine Decreases Movement and Propofol Requirements for Pediatric Lumbar Puncture During Deep Sedation: A Randomized, Placebo-Controlled, Double Blind Trial. J Pediatr Hematol Oncol. 2022 Jan 01;44(1):e213-e216. doi: 10.1097/MPH.0000000000002169. PMID: 33885035; PMCID: PMC8528901.
Copy Download .nbib Format: NLM
Budget Impact Analysis of Comprehensive Genomic Profiling in Patients With Advanced Non-Small-Cell Lung Cancer.

JCO precision oncology

Harvey MJ, Cunningham R, Sawchyn B, Montesion M, Reddy P, McBride A, Chawla AJ.
PMID: 34994647
JCO Precis Oncol. 2021 Nov;5:1611-1624. doi: 10.1200/PO.20.00540.

PURPOSE: This study assessed the economic impact of increased use of comprehensive genomic profiling (CGP) versus conventional testing strategies among patients with advanced non-small-cell lung cancer (aNSCLC) from a US commercial health plan perspective.METHODS: A decision analytic model was...

Cite
Harvey MJ, Cunningham R, Sawchyn B, et al. Budget Impact Analysis of Comprehensive Genomic Profiling in Patients With Advanced Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2021;5:1611-1624doi: 10.1200/PO.20.00540.
Harvey, M. J., Cunningham, R., Sawchyn, B., Montesion, M., Reddy, P., McBride, A., & Chawla, A. J. (2021). Budget Impact Analysis of Comprehensive Genomic Profiling in Patients With Advanced Non-Small-Cell Lung Cancer. JCO precision oncology, 51611-1624. https://doi.org/10.1200/PO.20.00540
Harvey, Michael J, et al. "Budget Impact Analysis of Comprehensive Genomic Profiling in Patients With Advanced Non-Small-Cell Lung Cancer." JCO precision oncology vol. 5 (2021): 1611-1624. doi: https://doi.org/10.1200/PO.20.00540
Harvey MJ, Cunningham R, Sawchyn B, Montesion M, Reddy P, McBride A, Chawla AJ. Budget Impact Analysis of Comprehensive Genomic Profiling in Patients With Advanced Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2021 Nov;5:1611-1624. doi: 10.1200/PO.20.00540. PMID: 34994647.
Copy Download .nbib Format: NLM
Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study.

Leukemia research

McBride A, Daniel S, Driessen MT, Szende A, Choudhry A, Tian M, Ariely R, Thompson S.
PMID: 34530254
Leuk Res. 2021 Dec;111:106671. doi: 10.1016/j.leukres.2021.106671. Epub 2021 Jul 21.

BACKGROUND: Rituximab (chimeric anti-CD20 monoclonal antibody) treatment is approved for chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). Rituximab-abbs (first biosimilar approved in 2017) is expected to significantly reduce healthcare economic burden due to lower acquisition costs. This non-interventional,...

Cite
McBride A, Daniel S, Driessen MT, et al. Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study. Leuk Res. 2021;111:106671doi: 10.1016/j.leukres.2021.106671.
McBride, A., Daniel, S., Driessen, M. T., Szende, A., Choudhry, A., Tian, M., Ariely, R., & Thompson, S. (2021). Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study. Leukemia research, 111106671. https://doi.org/10.1016/j.leukres.2021.106671
McBride, Ali, et al. "Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study." Leukemia research vol. 111 (2021): 106671. doi: https://doi.org/10.1016/j.leukres.2021.106671
McBride A, Daniel S, Driessen MT, Szende A, Choudhry A, Tian M, Ariely R, Thompson S. Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study. Leuk Res. 2021 Dec;111:106671. doi: 10.1016/j.leukres.2021.106671. Epub 2021 Jul 21. PMID: 34530254.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 99 entries